PARIS--(BUSINESS WIRE)--Regulatory News: On 18 February 2025, HSBC Continental Europe's Board of Directors reviewed the second half year results and approved the consolidated financial statements for 2024. At HSBC, our ambition is to be the preferred and most trusted international financial partner for our clients. In Continental Europe, we are focused on serving corporate and institutional clients, with a particular focus on connecting them to international markets, financing and facilitating.

Cloud-based web development platform specialist Wix.com (WIX 1.82%) reported mixed fourth-quarter 2024 earnings on Wednesday, Feb. 19. Adjusted EPS of $1.93 easily beat the consensus analyst estimate of $1.59, but Q4 revenue of $460.5 million fell just shy of the $461 million forecast.

The revenue miss — driven by higher costs of food, beverage, packaging and bone-in chicken wings — offset a profit beat.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

Antofagasta PLC has bagged a double upgrade from JPMorgan analysts on expectations the miner could be a standout among peers on improving prospects for copper ahead. Granting an ‘overweight' rating, JPMorgan laid out expectations for fiscal stimulus measures at China's March National People's Congress meeting.

NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ:SAMG) is pleased to announce that J. Allen Gray has been promoted to Head of Institutional Business. In this role, he will oversee Silvercrest's institutional business, as well as consultant and client relations. Since joining Silvercrest in 2008, Mr. Gray has played a pivotal role in the success of the firm's institutional equity business. He is a Silvercrest Partner and Managing Director, and a member of the company's Executive Committee.

Building on proven targeting of the F H AB domain, Sonnet's ADC platform offers flexible payload capacity and controllable drug-antibody ratios (DAR)

Stock futures steady after S&P 500's record close. Fed minutes, inflation data, and trade policy could dictate the next move for US indices.

PHILADELPHIA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against CROCS, INC. (“Crocs” or the “Company”) (NASDAQ: CROX). The lawsuit has been filed on behalf of purchasers of CROCS securities between November 3, 2022 and October 28, 2024, inclusive (the “Class Period”).

EV maker Nikola Corporation filed for Chapter 11 bankruptcy protection on Wednesday after the embattled company faced “significant" macroeconomic challenges.

As Palantir (NASDAQ: PLTR) trades at a new all-time high, a Wall Street analyst is sounding caution, detailing key fundamental factors that could work against the stock.

With the semiconductor stocks slowing down to start the year, contrarians may have an opportunity to put a bit of new money to work.

Chipotle is looking to hire 20,000 additional employees for its upcoming "Burrito Season," the company's busiest time of the year running from March to May. Crew members at Chipotle can advance to a Restaurateur in as little as three and a half years, with a total potential compensation package of approximately $100,000 while leading a multi-million-dollar business.

WALTHAM, Mass., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that management will present at TD Cowen's 45th Annual Health Care Conference on Monday, March 3, 2025 at 9:50am ET in Boston.

Earnings keep spilling lower while the company fights changing consumer behaviors.

For investors seeking momentum, VanEck Steel ETF SLX is probably on the radar. The fund just hit a 52-week high and is up 29.7% from its 52-week low of $57.31per share.

Smaller than expected loss in Q4 GAAP earnings led to a pop over the century mark.

MONTREAL and CHARLOTTE, N.C., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it has received Notice of Allowance from the United States Patent and Trademark Office (USPTO) on a new Method of Use patent for etripamil nasal spray (proposed trade name CARDAMYST™), its lead investigational product for the management of paroxysmal supraventricular tachycardia (PSVT).

- Educational campaign aims to raise awareness and drive conversation about desmoid tumors, the devastating impact they have on patients' lives - STAMFORD, Conn. , Feb. 19, 2025 /PRNewswire/ -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, and Jennifer Fisher, jewelry designer and desmoid tumor patient advocate, are collaborating to increase understanding of desmoid tumors as well as to encourage patients to find a specialist, like an oncologist with experience treating desmoid tumors who can discuss available treatment options to manage their desmoid tumor.

Record 349 Net New Restaurants and 15.8% Unit Growth in 2024 Delivers 21st Consecutive Year of Same Store Sales Growth with 19.9% in 2024 DALLAS , Feb. 19, 2025 /PRNewswire/ -- Wingstop Inc. ("Wingstop" or the "Company") (NASDAQ: WING) today announced financial results for the fiscal fourth quarter and fiscal year ended December 28, 2024. Highlights for the fiscal fourth quarter 2024 compared to the fiscal fourth quarter 2023: System-wide sales increased 27.6% to $1.2 billion 105 net new openings in the fiscal fourth quarter 2024 Domestic restaurant AUV increased to $2.1 million Domestic same store sales increased 10.1% Digital …